Continued Use of Effective Contraception After Use of Emergency Contraception
1 other identifier
observational
7
1 country
1
Brief Summary
Women using an emergency contraceptive method must use back up protection for 1-2 weeks depending on method. The Copper-IUD is the most effective emergency contraceptive method. The investigators wish to explore if women choosing the Cooper IUD have a higher frequency of use of an effective contraceptive method 3 months and 6 months after the use of an emergency contraceptive method than women who choose to use the emergency contraceptive pill EllaOne (ulipristal acetate).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 3, 2014
CompletedFirst Posted
Study publicly available on registry
March 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedNovember 29, 2023
November 1, 2023
11 months
March 3, 2014
November 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Use of an effective contraceptive method
Use of pill, patch, ring, IUD, IUS, or injection 6 months after use of emergency contraceptive method
6 months after emergency contraceptive use
Study Arms (2)
Ulipristal acetate
Women choosing EllaOne as emergency contraception
Copper IUD
Women choosing copper IUD as emergency contraception
Eligibility Criteria
Women without contraception or with a failed contraceptive method seeking emergency contraception
You may qualify if:
- women over 18 years
- eligible for all emergency contraception
You may not qualify if:
- previous conisation
- known stenosis of the cervix
- signs of ongoing genital infection
- known uterine anomaly
- Known bleeding disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RFSU clinic
Stockholm, Sweden
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Obstetrics and Gynecology, PhD
Study Record Dates
First Submitted
March 3, 2014
First Posted
March 5, 2014
Study Start
March 1, 2014
Primary Completion
February 1, 2015
Study Completion
May 1, 2015
Last Updated
November 29, 2023
Record last verified: 2023-11